184 related articles for article (PubMed ID: 23823235)
1. FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain.
Sarabipour S; Hristova K
Biophys J; 2013 Jul; 105(1):165-71. PubMed ID: 23823235
[TBL] [Abstract][Full Text] [Related]
2. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
3. The A391E mutation enhances FGFR3 activation in the absence of ligand.
Chen F; Degnin C; Laederich M; Horton WA; Hristova K
Biochim Biophys Acta; 2011 Aug; 1808(8):2045-50. PubMed ID: 21536014
[TBL] [Abstract][Full Text] [Related]
4. Coupling of transmembrane helix orientation to membrane release of the juxtamembrane region in FGFR3.
Tamagaki H; Furukawa Y; Yamaguchi R; Hojo H; Aimoto S; Smith SO; Sato T
Biochemistry; 2014 Aug; 53(30):5000-7. PubMed ID: 25010350
[TBL] [Abstract][Full Text] [Related]
5. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
[TBL] [Abstract][Full Text] [Related]
6. The pathogenic A391E mutation in FGFR3 induces a structural change in the transmembrane domain dimer.
Mudumbi KC; Julius A; Herrmann J; Li E
J Membr Biol; 2013 Jun; 246(6):487-93. PubMed ID: 23727984
[TBL] [Abstract][Full Text] [Related]
7. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
Li E; You M; Hristova K
J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
[TBL] [Abstract][Full Text] [Related]
8. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
Sarabipour S; Hristova K
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
[TBL] [Abstract][Full Text] [Related]
9. FGFR3 unliganded dimer stabilization by the juxtamembrane domain.
Sarabipour S; Hristova K
J Mol Biol; 2015 Apr; 427(8):1705-14. PubMed ID: 25688803
[TBL] [Abstract][Full Text] [Related]
10. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
Li E; You M; Hristova K
Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM Dimer Structure.
Sarabipour S; Hristova K
J Mol Biol; 2016 Oct; 428(20):3903-3910. PubMed ID: 27596331
[TBL] [Abstract][Full Text] [Related]
12. A simple "proximity" correction for Förster resonance energy transfer efficiency determination in membranes using lifetime measurements.
Posokhov YO; Merzlyakov M; Hristova K; Ladokhin AS
Anal Biochem; 2008 Sep; 380(1):134-6. PubMed ID: 18559252
[TBL] [Abstract][Full Text] [Related]
13. Effect of pathogenic cysteine mutations on FGFR3 transmembrane domain dimerization in detergents and lipid bilayers.
You M; Spangler J; Li E; Han X; Ghosh P; Hristova K
Biochemistry; 2007 Oct; 46(39):11039-46. PubMed ID: 17845056
[TBL] [Abstract][Full Text] [Related]
14. Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
Merzlyakov M; Chen L; Hristova K
J Membr Biol; 2007 Feb; 215(2-3):93-103. PubMed ID: 17565424
[TBL] [Abstract][Full Text] [Related]
15. Role of dimerization efficiency of transmembrane domains in activation of fibroblast growth factor receptor 3.
Volynsky PE; Polyansky AA; Fakhrutdinova GN; Bocharov EV; Efremov RG
J Am Chem Soc; 2013 Jun; 135(22):8105-8. PubMed ID: 23679838
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary dimer interfaces of the fibroblast growth factor receptor 3 transmembrane domain: characterization via multiscale molecular dynamics simulations.
Reddy T; Manrique S; Buyan A; Hall BA; Chetwynd A; Sansom MS
Biochemistry; 2014 Jan; 53(2):323-32. PubMed ID: 24397339
[TBL] [Abstract][Full Text] [Related]
17. Structure of FGFR3 transmembrane domain dimer: implications for signaling and human pathologies.
Bocharov EV; Lesovoy DM; Goncharuk SA; Goncharuk MV; Hristova K; Arseniev AS
Structure; 2013 Nov; 21(11):2087-93. PubMed ID: 24120763
[TBL] [Abstract][Full Text] [Related]
18. Death Receptor 5 Activation Is Energetically Coupled to Opening of the Transmembrane Domain Dimer.
Vunnam N; Campbell-Bezat CK; Lewis AK; Sachs JN
Biophys J; 2017 Jul; 113(2):381-392. PubMed ID: 28746849
[TBL] [Abstract][Full Text] [Related]
19. Hill coefficient analysis of transmembrane helix dimerization.
Soong R; Merzlyakov M; Hristova K
J Membr Biol; 2009 Jul; 230(1):49-55. PubMed ID: 19603128
[TBL] [Abstract][Full Text] [Related]
20. The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain.
You M; Li E; Hristova K
Biochemistry; 2006 May; 45(17):5551-6. PubMed ID: 16634636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
